BDBM506203 (S)-6-(((2-methyl-1-oxo-1,2- dihydroisoquinolin-5- yl)(1-(3-methyloxetan-3-yl)- 1H-1,2,3-triazol-4- yl)methyl)amino)-4- (neopentylamino)quinoline- 3,8-dicarbonitrile::US11066414, Compound 853

SMILES Cn1ccc2c([C@H](Nc3cc(C#N)c4ncc(C#N)c(NCC(C)(C)C)c4c3)C3=CN(C4(C)COC4)NN3)cccc2c1=O

InChI Key InChIKey=HSFHNQKNHPAYNH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 506203   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 506203BDBM506203(US11066414, Compound 853 | (S)-6-(((2-methyl-1-oxo...)
Affinity DataIC50: 1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
US Patent